Yen-Lin Chen Selected Research

Yen-Lin Chen Research Topics

Disease

38	Neoplasms (Cancer) 04/2022 - 08/2006
18	Sarcoma (Soft Tissue Sarcoma) 09/2021 - 06/2010
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 07/2011
10	Type 2 Diabetes Mellitus (MODY) 06/2022 - 05/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2014
9	Insulin Resistance 01/2021 - 06/2013
7	Neoplasm Metastasis (Metastasis) 10/2020 - 08/2006
7	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 10/2011
6	Hypertension (High Blood Pressure) 08/2022 - 11/2011
5	Chordoma 04/2022 - 07/2013
4	Inflammation (Inflammations) 01/2021 - 01/2016
4	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2012
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 11/2009
4	Lung Neoplasms (Lung Cancer) 01/2018 - 10/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2016
3	Hyperglycemia 01/2020 - 10/2017
2	Wounds and Injuries (Trauma) 04/2022 - 01/2018
2	Chondrosarcoma 09/2021 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 08/2014
2	Glioma (Gliomas) 01/2021 - 07/2019
2	Decompression Sickness (Bends) 12/2020 - 12/2018
2	Prediabetic State (Prediabetes) 03/2020 - 01/2016
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 10/2018
2	Adenocarcinoma 01/2020 - 04/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 07/2015
2	Leukemia 01/2019 - 01/2018
2	Chronic Disease (Chronic Diseases) 07/2017 - 01/2015
2	Margins of Excision 10/2016 - 08/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 07/2013
2	Cachexia 01/2016 - 01/2015
2	Body Weight (Weight, Body) 01/2016 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 01/2015
2	Atrophy 01/2016 - 01/2015
2	Hyperplasia 05/2013 - 08/2006
2	Aggressive Fibromatosis (Desmoid) 01/2013 - 12/2012
1	Lymph Node Tuberculosis (Scrofula) 09/2022
1	Stomach Neoplasms (Stomach Cancer) 06/2022
1	COVID-19 04/2022
1	Thrombocytopenia (Thrombopenia) 04/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Refractive Errors (Refractive Error) 01/2022

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
10	Protons (Proton)IBA 04/2022 - 06/2010
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2007
4	CateninsIBA 04/2021 - 01/2013
4	Messenger RNA (mRNA)IBA 10/2020 - 03/2015
4	protein phosphatase 5IBA 12/2018 - 10/2017
4	ErbB Receptors (EGF Receptor)IBA 02/2015 - 04/2014
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2014
3	RNA (Ribonucleic Acid)IBA 12/2020 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 11/2011
3	Retinaldehyde (Retinal)IBA 01/2020 - 10/2018
3	Triglycerides (Triacylglycerol)IBA 11/2019 - 10/2012
3	Alanine Transaminase (SGPT)IBA 01/2018 - 07/2011
3	AMP-Activated Protein KinasesIBA 01/2018 - 10/2017
3	Uric Acid (Urate)IBA 01/2015 - 10/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	CytokinesIBA 09/2021 - 01/2021
2	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2021 - 07/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 12/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 09/2019
2	Endothelin-1 (Endothelin 1)IBA 01/2020 - 10/2018
2	MucinsIBA 01/2020 - 04/2012
2	Biological ProductsIBA 09/2019 - 07/2013
2	Vasoconstrictor AgentsIBA 01/2019 - 10/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 12/2018 - 10/2017
2	EnzymesIBA 11/2018 - 05/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017 - 05/2015
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016 - 08/2014
2	Gemcitabine FDA Link 01/2016 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 08/2006
2	Insulin (Novolin)FDA Link 01/2015 - 01/2013
2	AndrogensIBA 05/2013 - 07/2012
2	monascuspiloinIBA 07/2012 - 01/2012
1	Angiotensin IIIBA 08/2022
1	AlbuminsIBA 06/2022
1	CreatinineIBA 06/2022
1	Fibronectins (Fibronectin)IBA 06/2022
1	VaccinesIBA 04/2022
1	AntibodiesIBA 04/2022
1	Platelet Factor 4IBA 04/2022
1	ChAdOx1 nCoV-19IBA 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	CurcuminIBA 01/2022
1	(3,5- bis((4- fluorophenyl)methylidene)- 1- ((1- hydroxy- 2,2,5,5- tetramethyl- 2,5- dihydro- 1H- pyrrol- 3- yl)methyl)piperidin- 4- one)IBA 01/2022

Therapy/Procedure

30	Radiotherapy 04/2022 - 06/2010
16	Therapeutics 09/2022 - 08/2006
11	Drug Therapy (Chemotherapy) 10/2020 - 12/2014
5	Neoadjuvant Therapy 01/2020 - 11/2011
4	Proton Therapy 01/2017 - 11/2009
3	Aftercare (After-Treatment) 01/2016 - 11/2009
2	Renal Dialysis (Hemodialysis) 10/2019 - 01/2014
1	Negative-Pressure Wound Therapy 04/2022